Evidence map›Paper›PMID 31881954›Full record

ArticleBMC psychiatry2019

Psychiatric advance directives for people living with schizophrenia, bipolar I disorders, or schizoaffective disorders: Study protocol for a randomized controlled trial - DAiP study.

Aurélie Tinland, Léa Leclerc, Sandrine Loubière, Frederic Mougeot, Tim Greacen, Magali Pontier, Nicolas Franck, Christophe Lançon, Mohamed Boucekine, Pascal Auquier

Registry-linked trialAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03630822 (Experimentation of a Protocol of Psychiatric Advance Directives), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03630822 nacompletednot on this map

Experimentation of a Protocol of Psychiatric Advance Directives: Randomized Controlled Multi-site Trial

TypeinterventionalSponsorAssistance Publique Hopitaux De MarseilleRan2019 to 2022Enrolled399ConditionsSchizophrenia, Bipolar I DisorderArmsPsychiatric Advanced Directive, Standard care
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aurélie TinlandSchool of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, Aix-Marseille University, 27 Boulevard Jean Moulin, F-13005, Marseille Cedex 5, France. aurelie.tinland@gmail.com.ORCID 0000-0002-8168-930X
Léa LeclercSchool of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, Aix-Marseille University, 27 Boulevard Jean Moulin, F-13005, Marseille Cedex 5, France.
Sandrine LoubièreSchool of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, Aix-Marseille University, 27 Boulevard Jean Moulin, F-13005, Marseille Cedex 5, France.
Frederic MougeotCentre Max Weber, UMR 5283 - Centre hospitalier Le Vinatier, Lyon, France.
Tim GreacenMental Health and Social Sciences Research Unit, Paris Psychiatry and Neurosciences University Hospital Group, Paris, France.
Magali PontierDepartment of Psychiatry, Sainte-Marguerite University Hospital, F-13009, Marseille, France.
Nicolas FranckResource center of psychosocial rehabilitation, Centre hospitalier Le Vinatier, UMR 5229, CNRS & Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Christophe LançonSchool of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, Aix-Marseille University, 27 Boulevard Jean Moulin, F-13005, Marseille Cedex 5, France.
Mohamed BoucekineSchool of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, Aix-Marseille University, 27 Boulevard Jean Moulin, F-13005, Marseille Cedex 5, France.
Pascal AuquierSchool of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, Aix-Marseille University, 27 Boulevard Jean Moulin, F-13005, Marseille Cedex 5, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCompulsory admission to psychiatric hospital is rising despite serious ethical concerns. Among measures to reduce compulsory admissions, Psychiatric Advance Directives (PAD) are the most promising, with intensive PAD (i.e. facilitated and shared) being the most effective. The aim of the study is to experiment Psychiatric Advance Directives in France.

methodsA multicentre randomized controlled trial and qualitative approach conducted from January 2019 to January 2021 with intent-to-treat analysis.

settingSeven hospitals in three French cities: Lyon, Marseille, and Paris. Research assistants meet each participant at baseline, 6 months and 12 months after inclusion for face-to-face interviews.

participants400 persons with a DSM-5 diagnosis of bipolar I disorder (BP1), schizophrenia (SCZ), or schizoaffective disorders (SCZaff), compulsorily admitted to hospital within the last 12 months, with capacity to consent (MacCAT-CR), over 18 years old, and able to understand French.

interventionsThe experimental group (PAD) (expected n = 200) is invited to fill in a document describing their crisis plan and their wishes in case of loss of mental capacity. Participants meet a facilitator, who is a peer support worker specially trained to help them. They are invited to nominate a healthcare agent, and to share the document with them, as well as with their psychiatrist. The Usual Care (UC) group (expected n = 200) receives routine care. MAIN OUTCOMES AND MEASURES: The primary outcome is the rate of compulsory admissions to hospital during the 12-month follow-up. Secondary outcomes include quality of life (S-QoL18), satisfaction (CSQ8), therapeutic alliance (4-PAS), mental health symptoms (MCSI), awareness of disorders (SUMD), severity of disease (ICG), empowerment (ES), recovery (RAS), and overall costs. DISCUSSION: Implication of peer support workers in PAD, potential barriers of supported-decision making, methodological issues of evaluating complex interventions, evidence-based policy making, and the importance of qualitative evaluation in the context of constraint are discussed.

trial registrationClinicalTrials.gov identifier: NCT03630822. Registered 14th August 2018.

Indexed as

Bipolar DisorderCommitment of Persons with Psychiatric DisordersPsychotic DisordersSchizophreniaAdultAdvance DirectivesFemaleFranceHumansMaleMulticenter Studies as TopicQualitative ResearchQuality of LifeRandomized Controlled Trials as TopicYoung AdultAdvance decision makingCompulsory admissionFacilitated psychiatric advances directivesPeer support workersSupported decision making

Identifiers

PMID31881954
PMCPMC6935101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.